Om

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for pulmonary and inflammatory diseases. Its lead product candidate, seralutinib, is being studied for pulmonary hypertension, including pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company also works on other drug candidates for immune-driven and respiratory conditions, using an approach centered on discovering and advancing targeted treatments. Gossamer Bio Inc. plays a specialized role in the healthcare market by addressing serious diseases with significant unmet medical need through its research, development, and clinical trial programs. The company is headquartered in San Diego, California.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I GOSSAMER BIO MED ENDAVU: Køb Gossamer Bio ($4GB0) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Gossamer Bio, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.